Mediaco Holding Inc. (MDIA): Nasdaq/NYSE listing notice — MediaCo receives Nasdaq deficiency notice for bid price below $1.00, has until March 2024 to cure

Mediaco Holding Inc.

Received Nasdaq deficiency letter on Sept 15, 2023 for bid price below $1.00 for 31 consecutive business days.
Has 180 calendar days, until March 13, 2024, to regain compliance by closing at $1.00 or more for 10 consecutive days.
If not cured by March 13, 2024, may qualify for second 180-day compliance period if meets other listing standards.
Company may consider options including a reverse stock split to regain compliance.
Stock continues trading under symbol MDIA; no immediate effect on listing.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Mediaco Holding Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

September 15, 2023, MediaCo Holding Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 31 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Nasdaq deficiency letter has no immediate effect on the listing of the Company’s common stoc

View on SEC.gov

Browse all listing & compliance notices →

Mediaco Holding Inc. filing history →

Source: SEC EDGAR

accession 0000929638-23-002540

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.